Centers of Collaboration

Center for Brain Immunology and Glia (BIG)

At the University of Virginia's School of Medicine, BIG is designing vaccines and developing novel therapies with the potential to promote neuronal survival.  A goal of the Center is to elucidate the cellular and molecular mechanisms underlying the beneficial effects of immune cells in healthy and diseased CNS.

The Miami Project to Cure Paralysis 

In 1985, Barth A. Green, M.D. and NFL Hall of Fame linebacker Nick Buoniconti helped found The Miami Project to Cure Paralysis after Nick’s son, Marc, sustained a spinal cord injury during a college football game.  Today, The Miami Project is the world’s most comprehensive spinal cord injury research center, and a designated Center of Excellence at the University of Miami Miller School of Medicine.  The Miami Project’s international team is housed in the Lois Pope LIFE Center and includes more than 300 scientists, researchers, clinicians and support staff who take innovative approaches to the challenges of brain and spinal cord injury.  

Reeve-Irvine Research Center (RIRC)

RIRC is a basic science research facility devoted to the study of repair, regeneration, and recovery of function after spinal cord injury.  The mission of the RIRC is to find new treatments for spinal cord injury through the collaborative research and educational efforts of prominent scientists and clinicians both at the University of California, Irvine and around the world. 

National Institutes of Health (NIH)

The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency—making important discoveries that improve health and save lives. 


Academic Collaborators

Alban Gaultier, Ph.D., Assistant Professor Department of Neuroscience, University of Virginia  

Dr. Gaultier is an expert in Multiple Sclerosis (MS) as well as a co-inventor on the original IP from which Novoron was founded. Dr. Gaultier and Dr. Stiles have worked closely together since before Novoron’s inception to develop the foundational technology towards a therapeutic to enhance remyelination in MS

Jae K. Lee, Ph.D., Assistant Professor Department of Neurologic Surgery, The Miami Project to Cure Paralysis, University of Miami

Dr. Lee has over a decade of experience as a researcher in spinal cord regeneration. As a member of the Miami Project, he is a member of a team that has become a world leader in innovative therapeutic approaches to spinal cord injury, and has become a hub for associated clinical trials.

Oswald Steward, Ph.D., Director Reeve-Irvine Research Center, UC Irvine

Dr. Steward is a world-renowned, award winning neuroscientist and leader in the field of spinal cord injury. Dr. Steward’s lab is responsible for foundational in vivo studies underlying Novoron’s technology.

Stephanie Willerth, Ph.D., Professor Mechanical Engineering, University of Victoria

Dr. Willerth is an expert in modern drug-delivery techniques such as nanoparticles and synthetic matrices. Additionally, she specializes in innovative approaches to augment stem cell-based approaches to restore function after spinal cord injury. Dr. Willerth’s lab is working closely with Novoron to investigate alternative administrative approaches for Novoron’s lead compounds, and we are preparing for pilot studies to investigate the ability of such compounds to facilitate integration and therapeutic benefit when used in conjunction with stem cell therapies.